Posters

EBMT 2020: Successful and safe treatment of intestinal Graft-versus-Host Disease (GvHD) with pooled-donor full ecosystem microbiota therapeutics

Date : août 28, 2020

MaaT Pharma annonce le lancement d’une nouvelle campagne de collecte et de production pour son portefeuille de biothérapies à base de microbiome

MaaT Pharma to Announce Clinical Data with its Lead Microbiota Biotherapeutic in Intestinal Acute GvHD at Virtual 46th Annual Meeting of the European Society for Blood and Marrow Transplantation (EBMT)